Supply of the medicinal product Lanreotide

Summary

The tender concerns the supply of 73 packages of Lanreotidum, a 120 mg injectable solution containing lanreotide, for a six-month period. The bidder must be authorised to conduct the wholesale trade of medicinal products in Poland and must submit the required declaration and supporting evidence. Offers must be submitted electronically through the contracting authority’s procurement platform by 1 September 2026 at 10:00. Price is the only award criterion and carries 100% of the weighting. No bid guarantee or performance security is required.